The firm touted new assays, provided an update on its nanopore sequencer, and offered insights into upcoming pipeline ...

The initial focus of the partnership will be on trio-based whole genome sequencing for critically ill newborns.

Roche and Broad Clinical Labs collaborate to accelerate adoption of cutting-edge SBX sequencing technology: Basel Saturday, May 24, 2025, 10:00 Hrs [IST] Roche announced a strateg ...

Roche raised the curtain on its novel approach to DNA sequencing earlier this year, and now it's working with the Broad ...

The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche's SBX sequencing technology1, with an initial focus on critically ill newborns and their parents.

LHV research points out the following aspects about the EfTEN Real Estate Fund AS: (i) interest costs continue to decrease ...

The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing ...

Our Roche SBX technology has the potential to really be transformational. And you see here on this slide some of the data presented at AGBT from the Broad Institute. Now here the Broad Institute ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning the President Trump administration for an exemption. Roche is trying ...

In diagnostics, Roche is preparing to unveil its novel SBX sequencing technology, which combines improved DNA molecule signaling with high-throughput sensor modules to deliver faster and more ...

Roche Holding AG (SIX: ROG) reported a 6% increase in group sales for the first quarter of 2025, with total revenue reaching CHF 15.4 billion compared to CHF 14.4 billion in the same period last year.

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...